SEC Filing Details
Document Details
Form
Filing Date
March 21, 2023
Document Date
February 23, 2023
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.